Understanding the breast cancer patient journey in 2025
October is Breast Cancer Awareness Month. While pink ribbons and fundraising campaigns help bring...
October is Breast Cancer Awareness Month. While pink ribbons and fundraising campaigns help bring...
In a recent webinar, the HealthVerity team including Alexa Woodward, Ph.D., Director of Strategic...
When we introduced HealthVerity eXOs, an agentic AI platform powered by Medeloop, in our recent...
The evolution of heart failure treatment and research Heart failure remains one of the most...
The rise of GLP-1 therapies and the evolution of obesity treatment Over 40% of adults in the U.S....
Recently, HealthVerity COO and co-founder Andrew Goldberg spoke at a timely webinar: Back to...
Why real-world data matters in epilepsy research Epilepsy affects millions of adults in the United...
Turning claims into interoperable evidence More means more. In a world where anyone can make...
Thank you for visiting HealthVerity at Fierce 2025 HealthVerity had a fantastic week at Fierce...
At HealthVerity, community is at the heart of who we are. Each year, our team members come together...
In atopic dermatitis, 23% of new patient starts come from HCPs that brand teams either deprioritize or don’t have in their data at all. One in three top-decile prescribers in that same market saw zero new patient starts over a 22-month stretch. In ob...